Cure My Disease

Don't miss your cure!

 Log in / Sign up

Acupressure may ease fatigue in young cancer survivors

NCT ID NCT06442891

Completed Symptom relief Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether young cancer survivors (ages 15-39) could learn to do acupressure on themselves to reduce fatigue. 42 people who had finished cancer treatment at least three months ago and still felt tired took part. They used a special tool and a phone app to apply pressure to specific body points. The study checked if people would stick with it and if their tiredness improved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acupressure (self-administered relaxing acupressure using an AcuWand device and mobile app)
What this could lead to
If it works, this could offer a simple, drug-free way for young cancer survivors to manage fatigue at home.
What could go wrong
This is a small pilot study with only 42 participants, so results may not apply to everyone. It also relies on people remembering to do acupressure themselves, which may be hard to keep up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.